Clinical Trial Update: RCVS: The Rational Approach to Diagnosis and Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining diagnosis and treatment for Reversible Cerebral Vasoconstriction Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reversible Cerebral Vasoconstriction Syndrome

Snippet

Sponsor: Johns Hopkins University | Conditions: Reversible Cerebral Vasoconstriction Syndrome | Phase 4 | Status: WITHDRAWN